Align Technology: revenue, profit and cash flow

In fiscal 2025, Align Technology had revenue of $4.03B, up 16.9% a year on average since 2015, and net income of $410M (10.2% of revenue). It has 11% fewer shares than in 2015.

Revenue, fiscal 2025

$4.03B+16.9% a year

average annual revenue growth since 2015 · +0.9% vs 2024

Net income, 2025

$410M

10.2% of revenue

Diluted EPS, 2025

$5.65

12.3% a year since 2015

Revenue growth, 5 years

10.3% a year

since 2020

Shares, 2025

72.6M

−11.0% since 2015

Free cash flow, 2025

$491M

$593M from operations − $102M capex

Ticker: ALGN · Nasdaq
Sector: Health Care
Sub-industry: Health Care Supplies
Headquarters: Tempe, Arizona
Founded: 1997
In the S&P 500 since: June 19, 2017
Latest fiscal year: 2025, ended December 31, 2025
SEC filer: Align Technology Inc · CIK 0001097149

Revenue and net income

Revenue went from $304M in 2008 to $4.03B in 2025. Net loss in 2009.

RevenueNet income

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Diluted earnings per share

Diluted EPS went from $1.18 in 2008 to $5.65 in 2025. Ten-year growth: 12.3% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Shares outstanding

11.0% fewer shares in 2025 than in 2015 (81.5M → 72.6M): buybacks outweighed new shares.

Fiscal years · diluted weighted-average shares, adjusted for splitsSource: SEC EDGAR (company filings)

Operating cash flow, capex and free cash flow

Free cash flow (operating cash flow minus capital expenditure) was $491M in 2025, 12.2% of revenue.

Operating cash flowCapital expenditureFree cash flow

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Year by year

Fiscal year	Revenue	Net income	Net margin	Diluted EPS	Shares	Operating cash flow	Capex	Free cash flow
2025	$4.03B	$410M	10.2%	$5.65	72.6M	$593M	$102M	$491M
2024	$4.0B	$421M	10.5%	$5.62	75M	$738M	$116M	$623M
2023	$3.86B	$445M	11.5%	$5.81	76.6M	$786M	$178M	$608M
2022	$3.73B	$362M	9.7%	$4.61	78.4M	$569M	$292M	$277M
2021	$3.95B	$772M	19.5%	$9.69	79.7M	$1.17B	$401M	$771M
2020	$2.47B	$1.78B	71.8%	$22.41	79.2M	$662M	$155M	$507M
2019	$2.41B	$443M	18.4%	$5.53	80.1M	$747M	$150M	$598M
2018	$1.97B	$400M	20.4%	$4.92	81.4M	$555M	$223M	$331M
2017	$1.47B	$231M	15.7%	$2.83	81.8M	$439M	$196M	$243M
2016	$1.08B	$190M	17.6%	$2.33	81.5M	$248M	$70.6M	$177M
2015	$845M	$144M	17.0%	$1.77	81.5M	$238M	$53.5M	$185M
2014	$762M	$146M	19.1%	$1.77	82.3M	$227M	$24.1M	$203M
2013	$660M	$64.3M	9.7%	$0.78	82.6M	$186M	$19.4M	$167M
2012	$560M	$58.7M	10.5%	$0.71	83M	$134M	$38.3M	$95.4M
2011	$480M	$66.7M	13.9%	$0.83	80.3M	$130M	$30.4M	$100M
2010	$387M	$74.3M	19.2%	$0.95	78.1M	$130M	$18M	$111M
2009	$312M	−$31.3M	−10.0%	−$0.45	69.1M	$74.2M	$7.19M	$67M
2008	$304M	$80M	26.3%	$1.18	68.1M	$39.7M	$14.3M	$25.4M

Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.

About these figures

No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.

Other Health Care Supplies companies

COO

Cooper Companies (The)

revenue $4.09B (2025)

WST

West Pharmaceutical Services

revenue $3.07B (2025)

All 60 Health Care companies

Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.